• Explore /
  • Poster
  • / Patient-specific tumor-informed circulating tumor DNA (ctDNA) assay to predict cancer recurrence in patients with resected pancreatic cancer.

Patient-specific tumor-informed circulating tumor DNA (ctDNA) assay to predict cancer recurrence in patients with resected pancreatic cancer.

Abstract Poster

Authors

null

Xiuchao Wang

Tianjin Medical University Cancer Institute and Hospital, Tianjin, China;

Xiuchao Wang , Hongwei Wang , Xinyun Chen , Yuxiao Liu , Tiansuo Zhao , Song Gao , Jian Wang , Weidong Ma , Chuntao Gao , Jihui Hao

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 744)

DOI

10.1200/JCO.2023.41.4_suppl.744

Abstract #

744

Poster Bd #

M11

Abstract Disclosures

Similar Posters

First Author: Hiroki Yukami

First Author: Binod Dhakal

Poster

2020 ASCO Virtual Scientific Program

Circulating tumor DNA as a promising biomarker of relapse risk for stage II-III colorectal cancer.

Circulating tumor DNA as a promising biomarker of relapse risk for stage II-III colorectal cancer.

First Author: Gong Chen

First Author: Amanda Oon Lim Seet